SCHEMBL7530543

SCHEMBL7530543

Cn1cc(C2=C(c3cn(C)c4cc(-n5ccnc5)ccc34)C(=O)NC2=O)c2ccc(C#N)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 7/20 0.45
IDH1 O75874 2/20 0.45
CDK2 P24941 2/20 0.43
CCNE2 O96020 1/20 0.43
CDK4 P11802 1/20 0.43
CCND1 P24385 1/20 0.43
CCNE1 P24864 1/20 0.43
PDE2A O00408 1/20 0.42
PDE1A P54750 1/20 0.42
PDE1B Q01064 1/20 0.42
PDE3B Q13370 1/20 0.42
PDE1C Q14123 1/20 0.42
PDE3A Q14432 1/20 0.42
CCNT1 O60563 1/20 0.41
PIM1 P11309 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK9 P50750 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
BRD4 O60885 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7531023 0.86 CDK2 (0.62) GSK3BIDH1CDK2CCNE2CDK4
SCHEMBL7524890 0.85 GSK3B (0.56) GSK3BIDH1CDK2CCNE2CDK4
SCHEMBL7582378 0.83 GSK3B (0.53) GSK3BIDH1QPCT
SCHEMBL7990667 0.82 GSK3B (0.45) GSK3BIDH1CDK2CCNE2CDK4
SCHEMBL7525540 0.80 ALK (0.49) GSK3BCDK2CCNE2CDK4CCND1
SCHEMBL6952413 0.79 CCNE2 (0.71) GSK3BCDK2CCNE2CDK4CCND1
SCHEMBL7497372 0.79 GSK3B (0.58) GSK3BCDK2CCNE2CDK4CCND1
SCHEMBL7502705 0.78 GSK3B (0.54) GSK3BCDK2CCNE2CDK4CCND1
SCHEMBL7526149 0.77 GSK3B (0.53) GSK3BCDK2CCNE2CDK4CCND1
SCHEMBL7926652 0.76 GSK3B (0.58) GSK3BCDK2CCNE2CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281356-B1 ANTICANRCER AGENTS HOFFMANN-LA ROCHE INC. 2001-08-28 US claimed
EP-1242409-A2 SUBSTITUTED BISINDOLYLMALEIMIDES F. HOFFMANN-LA ROCHE AG (CH) 2002-09-25 EP disclosed
US-6281356-B1 ANTICANRCER AGENTS HOFFMANN-LA ROCHE INC. 2001-08-28 US disclosed
WO-2001046178-A2 SUBSTITUIERTE BISINDOLYMALEIMIDE F. HOFFMANN-LA ROCHE AG (CH) 2001-06-28 WO disclosed